Alnylam Pharmaceuticals
ALNY
#378
Rank
S$78.43 B
Marketcap
S$593.68
Share price
-1.55%
Change (1 day)
76.13%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Number of shares outstanding for Alnylam Pharmaceuticals (ALNY)

Number of shares outstanding as of December 2025 : 131,447,000

According to Alnylam Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 131,447,000. At the end of 2025 the company had 131,447,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Alnylam Pharmaceuticals from 2003 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20250.13 B2.22%
20240.12 B2.37%
20230.12 B1.9%
20220.12 B2.92%
20210.11 B3.01%
20200.11 B4.05%
20190.11 B10.57%
20180.10 B5.12%
201796.13 M11.99%
201685.84 M1.15%
201584.87 M10.28%
201476.95 M22.33%
201362.9 M21.4%
201251.82 M21.49%
201142.65 M1.26%
201042.12 M1%
200941.7 M1.24%
200841.19 M5.57%
200739.02 M21.49%
200632.12 M53.59%
200520.91 M7.21%
200419.5 M2209.85%
20030.84 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Arrowhead Pharmaceuticals
ARWR
139,039,000 5.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
103,600,000-21.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
100,237,000-23.74%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
777,154,808 491.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
66,174,550-49.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
1,926,000,000 1,365.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
2,436,200,000 1,753.37%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
1,147,000,000 772.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel